Anti-HER2 neoadjuvant treatment may have an impact on discordance between preoperative core needle biopsy and surgical specimen in early breast cancer

Publication date: Available online 21 February 2017
Source:European Journal of Surgical Oncology (EJSO)
Author(s): Kadri Altundag




http://ift.tt/2lpbIGB